Cell Therapy Market to Surpass US$ 54.6 Bn by 2032, Latest Study by TMR

The latest analysis report on the 𝐜𝐞𝐥𝐥 𝐭𝐡𝐞𝐫𝐚𝐩𝐲 𝐦𝐚𝐫𝐤𝐞𝐭, recently published by Transparency Market Research, reveals that global sales reached US$ 8.5 billion in 2021. Projections indicate a remarkable growth trajectory, with an anticipated market expansion of 18.7% to attain US$ 54.6 Bn from 2022 to 2032, surpassing historical growth rates. Among the segments, autologous therapies are forecasted to emerge as the leading revenue generator, with an expected Compound Annual Growth Rate (CAGR) exceeding 18% from 2022 to 2032.

𝐆𝐫𝐚𝐛 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=63273&utm_source=OpenPR&utm_campaign=MansiR_OpenPR

𝐖𝐡𝐚𝐭 𝐅𝐚𝐜𝐭𝐨𝐫𝐬 𝐚𝐫𝐞 𝐏𝐫𝐨𝐩𝐞𝐥𝐥𝐢𝐧𝐠 𝐂𝐞𝐥𝐥 𝐓𝐡𝐞𝐫𝐚𝐩𝐲 𝐃𝐞𝐦𝐚𝐧𝐝?

Cell and gene therapies (CGTs) represent cutting-edge technology for treating severe and rare diseases.
LUXTURNA, a therapy targeting a hereditary retinal illness causing blindness, is among several such treatments available.

CGT signifies a significant medical advancement, notably as the first curative gene therapy approved for use.
In August 2020, the FDA approved Novartis' Kymriah for refractory follicular lymphoma, marking a milestone in regenerative medicine.

July 2020 saw FDA approval for brexucabtagene Acelus, a CAR T-cell therapy for mantle cell lymphoma patients.
Ongoing development efforts are evident, with over 750 CGT studies involving around 30,000 patients as of June 2020.

CGT drugs comprise approximately 12% of the pharmaceutical industry's clinical pipeline and at least 16% of the preclinical pipeline.
The demand for novel therapies, such as cancer and cardiovascular treatments, is driving research into cell-based solutions.

The Australian government launched the Cell Therapies Mission in November 2019, allocating US$ 102 million under the Medical Research Future Fund (MRFF) to incentivize stem cell research for new medicines.
Foster Innovation UK received GBP 267,000 in funding in September 2019 to support gel stabilization technology developed by Atelerix, with a focus on therapeutic applications.

𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬:

Novartis AG, Pharmicell, Osiris Therapeutics (Smith & Nephew), GlaxoSmithKline, Anterogen, IMFS, Stemedica Cell Technologies, NuVasive, BioNTech, Kolon TissueGene, JCR Pharmaceuticals, Cells for Cells, and Vericel Corporation.

𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐬:

By Use Type

Clinical use
Therapeutic Area
Cell Type
Research Use

By Therapy Type

Allogenic Therapies
Autologous Therapies

By Region

North America
Latin America
Europe
APAC
MEA

𝐑𝐞𝐜𝐞𝐧𝐭 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬:

In April 2019, Hitachi Chemical Co. Ltd. bought apceth Biopharma GmbH to expand its foothold in the contract development and manufacturing organization (CDMO) industry for gene and cell therapies production.

In June 2021, Charles River Laboratories acquired a cellular and gene therapy contract manufacturer-to-manufacturing capabilities through the acquisition of CDMO Cognate BioServices.

In August 2021, Thermo Fisher Scientific paid US$ 859.7 million for Henogen S.A., Novasep's viral vector production firm in Belgium. This purchase strengthens its position in the cell and gene therapy manufacturing therapeutic sector.

In July 2019, Thermo Fisher Scientific paid US$ 1.7 billion for Brammer Bio, a business that manufactures viral vectors for gene and cell treatments.

𝐎𝐫𝐝𝐞𝐫 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.transparencymarketresearch.com/checkout.php?rep_id=63273<ype=S&utm_source=OpenPR&utm_campaign=MansiR_OpenPR

𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐫𝐞𝐧𝐝𝐬:

Emergence of personalized cell therapies
Integration of artificial intelligence and machine learning in cell therapy development
Shift towards off-the-shelf cell therapies
Collaborations and partnerships among pharmaceutical companies and research institutes

𝐅𝐮𝐭𝐮𝐫𝐞 𝐎𝐮𝐭𝐥𝐨𝐨𝐤:

The future of the cell therapy market appears promising, with continuous innovation and technological advancements driving the development of safer and more effective therapies. As research uncovers new applications and expands the understanding of cellular mechanisms, the landscape of healthcare is set to undergo transformative changes.

𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐭𝐮𝐝𝐲 𝐏𝐨𝐢𝐧𝐭𝐬:

Understanding patient demographics and disease prevalence
Assessing regulatory landscapes across different regions
Analyzing competitive strategies and market positioning of key players
Monitoring advancements in cell manufacturing and therapy delivery techniques
Identifying emerging opportunities in niche therapeutic areas

𝐁𝐫𝐨𝐰𝐬𝐞 𝐌𝐨𝐫𝐞 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐓𝐌𝐑:

𝐀𝐜𝐮𝐭𝐞 𝐌𝐲𝐞𝐥𝐨𝐢𝐝 𝐋𝐞𝐮𝐤𝐞𝐦𝐢𝐚 (𝐀𝐌𝐋) 𝐁𝐢𝐨𝐦𝐚𝐫𝐤𝐞𝐫 𝐓𝐞𝐬𝐭𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭- https://www.globenewswire.com/news-release/2023/03/15/2627542/0/en/Acute-Myeloid-Leukemia-AML-Biomarker-Testing-Market-to-Hit-USD-624-0-Mn-by-2031-Says-Transparency-Market-Research.html

𝐀𝐮𝐭𝐨𝐦𝐨𝐭𝐢𝐯𝐞 𝐋𝐞𝐚𝐭𝐡𝐞𝐫 𝐔𝐩𝐡𝐨𝐥𝐬𝐭𝐞𝐫𝐲 𝐌𝐚𝐫𝐤𝐞𝐭- https://www.globenewswire.com/news-release/2023/03/15/2627439/0/en/Automotive-Leather-Upholstery-Market-to-Reach-US-7-0-Bn-by-2031-Europe-is-expected-to-dominate-the-worldwide-market-Transparency-Market-Research-Inc.html

𝐀𝐛𝐨𝐮𝐭 𝐓𝐫𝐚𝐧𝐬𝐩𝐚𝐫𝐞𝐧𝐜𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com    
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube

This release was published on openPR.